The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 09, 2019

Filed:

Oct. 18, 2013
Applicant:

Wayne State University, Detroit, MI (US);

Inventors:

D. Randall Armant, Saint Clair Shores, MI (US);

Michael P. Diamond, Grosse Pointe Shores, MI (US);

Assignee:

Wayne State University, Detroit, MI (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/24 (2006.01); C12Q 1/6888 (2018.01); G01N 33/569 (2006.01); C12N 5/073 (2010.01);
U.S. Cl.
CPC ...
C12Q 1/24 (2013.01); C12N 5/0605 (2013.01); C12Q 1/6888 (2013.01); G01N 33/56966 (2013.01); C12N 2503/00 (2013.01); C12Q 2600/156 (2013.01); G01N 2333/70539 (2013.01); G01N 2800/368 (2013.01);
Abstract

A method of retrieving fetal cells from an endocervical sample by removing the mucus from the endocervical sample by disassociating fetal cells and maternal cells in the endocervical sample; and isolating disassociated fetal cells from other cells in the endocervical sample. Also provided is a method of retrieving fetal cells from an endocervical sample, by obtaining a mixture of disassociated cells prepared by the above method, treating the cells with a fetal-specific antibody, identifying cells that have bound to the fetal-specific antibody, and isolating the identified cells. The disassociated cell prepared by the above method can be analyzed and used for a variety of purposes including, but not limited to, the identification of fetal cells among cervical cells, determination of fetal cell density to predict high risk pregnancy, genetic analysis of fetal cells, and determination of growth factor or other biomarker expression to predict obstetrical disorders.


Find Patent Forward Citations

Loading…